From lipodystrophy syndromes to diabetes mellitus
- 1 May 2001
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 357 (9266), 1379-1381
- https://doi.org/10.1016/s0140-6736(00)04616-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Beacon: a novel gene involved in the regulation of energy balance.Diabetes, 2000
- Mouse models of lipodystrophy.Current Atherosclerosis Reports, 2000
- Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophyHuman Molecular Genetics, 2000
- Free fatty acids and insulin levels—relationship to leptin levels and body composition in various patient groups from South AfricaInternational Journal of Obesity, 1999
- A Gene for Congenital Generalized Lipodystrophy Maps to Human Chromosome 9q34Journal of Clinical Endocrinology & Metabolism, 1999
- PPARγ, the ultimate thrifty geneDiabetologia, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Improved glucose tolerance after effective lipid‐lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle’s cycle in its pathogenesis?Clinical Endocrinology, 1997
- Generalized lipodystrophy, congenital and acquired (lipoatrophy)Acta Paediatrica, 1996
- In Vitro Studies of Insulin Resistance in Patients With Lipoatrophic Diabetes: Evidence for Heterogeneous Postbinding DefectsDiabetes, 1988